Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aardvark Therapeutics, Inc. - Common Stock
(NQ:
AARD
)
9.980
+0.310 (+3.21%)
Streaming Delayed Price
Updated: 1:00 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
134,146
Open
9.870
Bid (Size)
9.750 (100)
Ask (Size)
10.80 (200)
Prev. Close
9.670
Today's Range
9.805 - 10.44
52wk Range
4.880 - 19.58
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Aardvark Therapeutics to Present at Upcoming Investor Conferences in December
November 25, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates
November 13, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
-30.3%
-30.3%
1 Month
-13.0%
-13.0%
3 Month
+20.2%
+20.2%
6 Month
-4.4%
-4.4%
1 Year
-30.3%
-30.3%
More News
Read More
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
November 11, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
This Aardvark Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday
↗
November 07, 2025
Via
Benzinga
Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025
November 04, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
November 03, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
Aardvark Therapeutics to Present at Upcoming Investor Conferences in November
November 03, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek
October 22, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome
October 08, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
This Coinbase Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
↗
October 01, 2025
Via
Benzinga
Aardvark Therapeutics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
September 23, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
September 04, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
Aardvark Therapeutics to Present at Upcoming Investor Conferences in September
August 27, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
August 13, 2025
Via
Benzinga
Aardvark Therapeutics Reports Q2 Loss
↗
August 13, 2025
Via
The Motley Fool
Aardvark Therapeutics Reports Second Quarter 2025 Financial Results and Provides Pipeline and Business Updates
August 13, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Discontinuation of GLP-1RA Therapy
August 12, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
July 18, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
Aardvark's Hunger-Suppressing Drug Promises Weight Loss Without GI Distress
↗
June 30, 2025
Via
Benzinga
Topics
Initial Public Offering
Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference
June 24, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions
May 19, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
These stocks are gapping in today's session
↗
May 15, 2025
Via
Chartmill
Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
May 14, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
May 07, 2025
From
Aardvark Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
April 29, 2025
Via
Benzinga
Frequently Asked Questions
Is Aardvark Therapeutics, Inc. - Common Stock publicly traded?
Yes, Aardvark Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Aardvark Therapeutics, Inc. - Common Stock trade on?
Aardvark Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aardvark Therapeutics, Inc. - Common Stock?
The ticker symbol for Aardvark Therapeutics, Inc. - Common Stock is AARD on the Nasdaq Stock Market
What is the current price of Aardvark Therapeutics, Inc. - Common Stock?
The current price of Aardvark Therapeutics, Inc. - Common Stock is 9.980
When was Aardvark Therapeutics, Inc. - Common Stock last traded?
The last trade of Aardvark Therapeutics, Inc. - Common Stock was at 11/28/25 01:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.